Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)

SHA:605266 Revenue

Jianzhijia Pharmaceutical Chain Group had revenue of 2.29B CNY in the quarter ending March 31, 2025, a decrease of -0.85%. This brings the company's revenue in the last twelve months to 9.26B, up 0.38% year-over-year. In the year 2024, Jianzhijia Pharmaceutical Chain Group had annual revenue of 9.28B with 2.23% growth.

• Revenue (ttm): 9.26B
• Revenue Growth: +0.38%
• P/S Ratio: 0.36
• Revenue / Employee: 525.07K
• Employees: 17,625
• Market Cap: 3.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.28B	202.15M	2.23%
Dec 31, 2023	9.08B	1.57B	20.84%
Dec 31, 2022	7.51B	2.28B	43.54%
Dec 31, 2021	5.23B	768.60M	17.21%
Dec 31, 2020	4.47B	937.83M	26.58%